These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25239189)

  • 1. Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.
    Alafuzoff I; Pikkarainen M; Neumann M; Arzberger T; Al-Sarraj S; Bodi I; Bogdanovic N; Bugiani O; Ferrer I; Gelpi E; Gentleman S; Giaccone G; Graeber MB; Hortobagyi T; Ince PG; Ironside JW; Kavantzas N; King A; Korkolopoulou P; Kovács GG; Meyronet D; Monoranu C; Nilsson T; Parchi P; Patsouris E; Revesz T; Roggendorf W; Rozemuller A; Seilhean D; Streichenberger N; Thal DR; Wharton SB; Kretzschmar H
    J Neural Transm (Vienna); 2015 Jul; 122(7):957-72. PubMed ID: 25239189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
    Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
    King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
    Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of TDP-43 pathology in FTLD-U subtypes.
    Mackenzie IR; Neumann M
    Acta Neuropathol; 2017 Jul; 134(1):79-96. PubMed ID: 28466142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry.
    Pikkarainen M; Hartikainen P; Alafuzoff I
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):280-98. PubMed ID: 18379439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontotemporal lobar degeneration with ubiquitinated tau-negative inclusions and additional alpha-synuclein pathology but also unusual cerebellar ubiquitinated p62-positive, TDP-43-negative inclusions.
    King A; Al-Sarraj S; Shaw C
    Neuropathology; 2009 Aug; 29(4):466-71. PubMed ID: 18715271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration.
    Yousef A; Robinson JL; Irwin DJ; Byrne MD; Kwong LK; Lee EB; Xu Y; Xie SX; Rennert L; Suh E; Van Deerlin VM; Grossman M; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2017 Sep; 5(1):68. PubMed ID: 28877758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin.
    Hiji M; Takahashi T; Fukuba H; Yamashita H; Kohriyama T; Matsumoto M
    Acta Neuropathol; 2008 Aug; 116(2):183-91. PubMed ID: 18584184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitinated p62-positive, TDP-43-negative inclusions in cerebellum in frontotemporal lobar degeneration with TAR DNA binding protein 43.
    Pikkarainen M; Hartikainen P; Alafuzoff I
    Neuropathology; 2010 Apr; 30(2):197-9. PubMed ID: 19622109
    [No Abstract]   [Full Text] [Related]  

  • 11. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43.
    Tan RH; Shepherd CE; Kril JJ; McCann H; McGeachie A; McGinley C; Affleck A; Halliday GM
    Acta Neuropathol Commun; 2013 Jul; 1(1):33. PubMed ID: 24252630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.
    Mann DM; Rollinson S; Robinson A; Bennion Callister J; Thompson JC; Snowden JS; Gendron T; Petrucelli L; Masuda-Suzukake M; Hasegawa M; Davidson Y; Pickering-Brown S
    Acta Neuropathol Commun; 2013 Oct; 1():68. PubMed ID: 24252525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
    Tsai KJ; Yang CH; Fang YH; Cho KH; Chien WL; Wang WT; Wu TW; Lin CP; Fu WM; Shen CK
    J Exp Med; 2010 Aug; 207(8):1661-73. PubMed ID: 20660618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions.
    Josephs KA; Lin WL; Ahmed Z; Stroh DA; Graff-Radford NR; Dickson DW
    Acta Neuropathol; 2008 Aug; 116(2):159-67. PubMed ID: 18553091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.
    Baborie A; Griffiths TD; Jaros E; Perry R; McKeith IG; Burn DJ; Masuda-Suzukake M; Hasegawa M; Rollinson S; Pickering-Brown S; Robinson AC; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):601-12. PubMed ID: 25185840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Carter D; Cairns NJ
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
    Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
    J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.